Skip to Content

HUTCHMED (China) Ltd ADR HCM

Morningstar Rating
$15.21 +0.12 (0.80%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HCM is trading within a range we consider fairly valued.
Price
$15.14
Fair Value
$27.22
Uncertainty
High
1-Star Price
$74.12
5-Star Price
$59.82
Economic Moat
Nyxdfbc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HCM is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$15.09
Day Range
$15.1815.39
52-Week Range
$10.7020.60
Bid/Ask
$15.19 / $15.23
Market Cap
$2.65 Bil
Volume/Avg
36,722 / 93,006

Key Statistics

Price/Earnings (Normalized)
26.30
Price/Sales
3.13
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.15%

Company Profile

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
1,990

Comparables

Valuation

Metric
HCM
09926
06628
Price/Earnings (Normalized)
26.3019.22
Price/Book Value
3.606.970.81
Price/Sales
3.138.047.49
Price/Cash Flow
17.7319.28
Price/Earnings
HCM
09926
06628

Financial Strength

Metric
HCM
09926
06628
Quick Ratio
2.585.461.50
Current Ratio
2.726.431.61
Interest Coverage
30.2026.84−33.53
Quick Ratio
HCM
09926
06628

Profitability

Metric
HCM
09926
06628
Return on Assets (Normalized)
11.29%24.23%−19.81%
Return on Equity (Normalized)
19.17%44.26%−29.44%
Return on Invested Capital (Normalized)
13.58%29.66%−22.89%
Return on Assets
HCM
09926
06628
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AQytd$90.8 Bil
MKKGY
Merck KGaA ADRXnpdzvf$74.4 Bil
HLN
Haleon PLC ADRTxx$38.7 Bil
VTRS
Viatris IncVqpxl$14.8 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRFxq$13.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRZnyh$12.9 Bil
CTLT
Catalent IncNsqvwtb$10.4 Bil
PRGO
Perrigo Co PLCGtbkr$3.6 Bil
CURLF
Curaleaf Holdings IncJwzf$3.5 Bil
PBH
Prestige Consumer Healthcare IncSjdjr$3.5 Bil

Sponsor Center